SPRY
ARS Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
ARS Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No other changes.
No other changes.
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
Annual filing, covered
10-K parsed · Mar 9 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 9 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; of ARS Pharmaceuticals, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; of ARS Pharmaceuticals, Inc.'s 6 closest co-movers, none share that code.
ARS Pharmaceuticals, Inc.
3.03
pre 3.01 −1.31%
| Manager | Value | % base | |
|---|---|---|---|
| RA Capital Management | $87.0M | 11.94% | 0.00% |
| Rubric | $68.4M | 9.39% | +6.76% |
| Orbimed | $66.4M | 9.11% | 0.00% |
| Deerfield | $60.1M | 8.25% | 0.00% |
| BlackRockindex-like | $42.5M | 5.84% | +5.97% |
| Manager | Value | % base | |
|---|---|---|---|
| RA Capital Management | $87.0M | 11.94% | 0.00% |
| Rubric | $68.4M | 9.39% | +6.76% |
| Orbimed | $66.4M | 9.11% | 0.00% |
| Deerfield | $60.1M | 8.25% | 0.00% |
| BlackRockindex-like | $42.5M | 5.84% | +5.97% |
−7.38%
vs ±22.2% implied · ×0.33
shaded = implied · ▲▼ = realized
Bull2
Bear2
Expected move
No implied move.